Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      WHO Revises Treatment Recommendations For Drug-Resistant TB

      Drug Development
      The World Health Organization (WHO) has released its revised consolidated recommendations for treating drug-resistant tuberculosis (DR-TB), which include significant advancements in the treatment options...

      By 2032, The Alzheimers Treatments Market Will Be $6.8 Bn

      Drug Development
      The global Alzheimer's therapeutics market is anticipated to develop at a compound annual growth rate (CAGR) of 9.3% and reach $6.8 billion by 2032, according...

      New Zealand Health Agencies Aim To Improve Clinical Trials

      Clinical Trials
      Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments...

      Canadian And US Developers To Test Psychedelic Drugs In UK

      Clinical Trials
      To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a...

      Future Biotech Platforms Likely To Depend Primarily On Urine

      News
      A mechanism that employs urea to begin the manufacturing of proteins in the massive amounts required by the biotech industry has been developed by...

      NICE Methodology Raises Concerns For Kidney Research UK

      News
       The National Institute for Health and Care Excellence's (NICE) draught guidance on medicines for COVID-19 patients has received a response from Kidney Research UK. It...

      As Per The WHO Assessment, AMR Monitoring Must Be Enhanced

      News
      Common bacterial illnesses are getting more and more resistant to treatments, according to the World Health Organization's (WHO) Global Antimicrobial Resistance and Use Surveillance...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.